Skip to main content

Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life.

Publication ,  Journal Article
Wang, S; Arizmendi, CJ; Chen, D; Lin, L; Blalock, DV; Huang, I-C; Thissen, D; DeWalt, DA; Pan, W; Reeve, BB
Published in: J Biopharm Stat
May 14, 2023

The impact of chronic diseases on health-related quality of life (HRQOL) in adolescents and young adults (AYAs) is understudied. Latent profile analysis (LPA) can identify profiles of AYAs based on their HRQOL scores reflecting physical, mental, and social well-being. This paper will (1) demonstrate how to use LPA to identify profiles of AYAs based on their scores on multiple HRQOL indicators; (2) explore associations of demographic and clinical factors with LPA-identified HRQOL profiles of AYAs; and (3) provide guidance on the selection of adult or pediatric versions of Patient-Reported Outcomes Measurement Information System® (PROMIS®) in AYAs. A total of 872 AYAs with chronic conditions completed the adult and pediatric versions of PROMIS measures of anger, anxiety, depression, fatigue, pain interference, social health, and physical function. The optimal number of LPA profiles was determined by model fit statistics and clinical interpretability. Multinomial regression models examined clinical and demographic factors associated with profile membership. As a result of the LPA, AYAs were categorized into 3 profiles: Minimal, Moderate, and Severe HRQOL Impact profiles. Comparing LPA results using either the pediatric or adult PROMIS T-scores found approximately 71% of patients were placed in the same HRQOL profiles. AYAs who were female, had hypertension, mental health conditions, chronic pain, and those on medication were more likely to be placed in the Severe HRQOL Impact Profile. Our findings may facilitate clinicians to screen AYAs who may have low HRQOL due to diseases or treatments with the identified risk factors without implementing the HRQOL assessment.

Duke Scholars

Published In

J Biopharm Stat

DOI

EISSN

1520-5711

Publication Date

May 14, 2023

Start / End Page

1 / 14

Location

England

Related Subject Headings

  • Statistics & Probability
  • 4905 Statistics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, S., Arizmendi, C. J., Chen, D., Lin, L., Blalock, D. V., Huang, I.-C., … Reeve, B. B. (2023). Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life. J Biopharm Stat, 1–14. https://doi.org/10.1080/10543406.2023.2210684
Wang, Suwei, Cara J. Arizmendi, Dandan Chen, Li Lin, Dan V. Blalock, I-Chan Huang, David Thissen, Darren A. DeWalt, Wei Pan, and Bryce B. Reeve. “Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life.J Biopharm Stat, May 14, 2023, 1–14. https://doi.org/10.1080/10543406.2023.2210684.
Wang S, Arizmendi CJ, Chen D, Lin L, Blalock DV, Huang I-C, et al. Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life. J Biopharm Stat. 2023 May 14;1–14.
Wang, Suwei, et al. “Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life.J Biopharm Stat, May 2023, pp. 1–14. Pubmed, doi:10.1080/10543406.2023.2210684.
Wang S, Arizmendi CJ, Chen D, Lin L, Blalock DV, Huang I-C, Thissen D, DeWalt DA, Pan W, Reeve BB. Applying latent profile analysis to identify adolescents and young adults with chronic conditions at risk for poor health-related quality of life. J Biopharm Stat. 2023 May 14;1–14.

Published In

J Biopharm Stat

DOI

EISSN

1520-5711

Publication Date

May 14, 2023

Start / End Page

1 / 14

Location

England

Related Subject Headings

  • Statistics & Probability
  • 4905 Statistics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences